Clinical trial
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux…
NCT00336219 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00336219 |
|---|---|
| Title | Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343) |
| Official title | COMPETITION: Investigation of Clinical Endpoints for Treatment-induced Gastroesophageal Reflux Disease (GERD) Symptom Changes |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | Pantoprazole |
| Enrollment | 628 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jun 13, 2006 |
| Last update posted | May 7, 2012 |
| Countries | Australia, Austria, Germany, Hungary |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: